Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy

Sarcoid Associated Pulmonary Hypertension (SAPH) is a common complication of sarcoidosis and is associated with poor prognosis. SAPH can be due to multiple synergistic mechanisms and current therapeutic strategies treat systemic sarcoidosis and pulmonary hypertension separately. Several studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Abston, Eric, Hon, Stephanie, Lawrence, Romy, Berman, Jeffrey, Govender, Praveen, Farber, Harrison W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569547/
https://www.ncbi.nlm.nih.gov/pubmed/33093789
http://dx.doi.org/10.36141/svdld.v37i2.9343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569547/
https://www.ncbi.nlm.nih.gov/pubmed/33093789
http://dx.doi.org/10.36141/svdld.v37i2.9343

Ejemplares similares